swissnex Demo Day
Join us online for virtual demos, pitches, a unique opportunity to meet the startups one-on-one, and mingle with an international audience on October 22nd!
Despite the current pandemic, our support for Swiss startups wanting to internationalize continues. We’re excited to announce that for the second time this year, we’re taking our swissnex Startup Bootcamp online, making our Demo Day available for audiences worldwide. This bootcamp’s cohort has a strong healthcare focus, and we’re happy to announce a new partnership with Swiss Healthcare Startups. The two winners of their Booster Program won an exclusive participation to our Fall bootcamp for which all seven finalist startups went through a challenging selection process, and target the US market.
This event will take place on Zoom, and the networking sessions will take place on Remo. To ensure the best event experience on Remo, please make sure to:
Join from a laptop ideally. If that is not an option, join from a tablet. If that is not an option, you can join from a mobile phone, but you might experience bugs because the mobile version is still in beta.
Startups
ASPIVIX | Mathieu HORRAS, Co-founder & CEO | aspivix.com
Every year, more than 80M women worldwide experience pain, bleeding and tissue tear when undergoing common gynecological procedures that require uterus access. This trauma is generated by the Cervical Tenaculum, an instrument with sharp hooks that pinch the cervix to generate traction. ASPIVIX is changing that by developing a next-generation vacuum-based cervical device that delivers the same maneuverability as the tenaculum without the reported patient trauma. This device is ideal to help address unplanned pregnancies, considered one of the most significant global public health issues, by increasing the adoption of Intrauterine Contraceptive Devices (IUD), the most effective reversible contraceptive option available today. ASPIVIX empowers women and makes them free to choose their contraception option without fear. Find them on Facebook, Instagram, Linkedin, Twitter, and YouTube.
Startups
ASPIVIX | Mathieu HORRAS, Co-founder & CEO | aspivix.com
Every year, more than 80M women worldwide experience pain, bleeding and tissue tear when undergoing common gynecological procedures that require uterus access. This trauma is generated by the Cervical Tenaculum, an instrument with sharp hooks that pinch the cervix to generate traction. ASPIVIX is changing that by developing a next-generation vacuum-based cervical device that delivers the same maneuverability as the tenaculum without the reported patient trauma. This device is ideal to help address unplanned pregnancies, considered one of the most significant global public health issues, by increasing the adoption of Intrauterine Contraceptive Devices (IUD), the most effective reversible contraceptive option available today. ASPIVIX empowers women and makes them free to choose their contraception option without fear. Find them on Facebook, Instagram, Linkedin, Twitter, and YouTube.
Auxivo AG| Volker Bartenbach, Co-founder & CEO. Michael Stucky, Co-founder & Chairman. Fabio Gobbo, Business Developer | auxivo.com
Auxivo is a spinoff from ETH Zurich developing the next generation of lightweight exoskeletons to improve workers‘ lives. Follow them on Facebook, Instagram, Linkedin, and Twitter.
JAMIE & I | Antonia Bolla, Founder | jamieandi.shop
Welcome to Your Personal Online Boutique with Sustainable Designers you’ll LOVE! Curated by Jamie, your personal artificially intelligent online stylist who curates your personal online boutique with a curated selection of sustainable designers tailored to your style. Follow them on Instagram, and Linkedin.
MYLEG | Giacomo Valle, Postdoctoral Researcher at ETHZ | my-leg.com
MYLEG is a non-invasive sensory feedback to improve Mobility and to promote cognitive prosthesis integration in people with leg amputation.
Neurosoft Bioelectronics | Nicolas Vachicouras, CEO & Karsten Bagger, CBO | neurosoft-bio.com
Neurosoft Bioelectronics develops implantable medical devices to interface with the brain and spinal cord to treat patients suffering from neurological disorders. Our main USP is that we are the only ones to have been able to combine extremely soft materials that match the mechanical properties of the nervous tissues with high-density electrodes. Thanks to these unique features, we can access some locations of the brain that are impossible to reach surgically otherwise. Our preliminary animal data also suggest that our soft electrodes reduce dramatically inflammation when implanted. Follow them on Linkedin and Twitter.
Optimo Medical AG | Harald P. Studer, CEO & Alexander van der Mey, CCO | optimo-medical.com
Optimo Medical AG is specialized in bio-mechanical analyses and simulation of the anterior eye. Since the companies founding in 2015, the team has built a steady reputation as the leading company in virtual trials for the anterior eye segment, and a global technology leader in patient specific astigmatism management. Follow them on Linkedin.
Scailyte | Peter Nestorov, CEO. Stefan Almestrand, Director Corporate Development. Andrius Serva, Business Development Manager. Agnieszka Sitarska, Business Development Associate | scailyte.com
Scailyte uses single cell technologies and AI to discover biomarkers for diseases in oncology and immunology. We have a number of patented biomarker signatures which we currently are developing into clinical diagnostic applications for hospitals and subsequently patients. Follow them on Linkedin.
Program
- 9:30am – Welcome
- 9:10am – Round 1 round of Startup Pitches (3min pitches / 3min Q&A)
- 9:35am – Networking Break (10min)
- 9:45pm – Round 2 Startup round of Pitches (3min pitches / 3min Q&A)
- 10:45am – Virtual Demo Tables and Networking
- 11:15am – End
iCal / Outlook
Event start time
-
Switzerland + San Francisco
9:00AM -
California
9:00AM -
USA
11:00AM -
Boston and New York
12:00PM -
Brazil
1:00PM -
China
12:00AM -
India
9:30PM -
Switzerland
6:00PM -
Boston
12:00PM -
San Francisco
9:00AM
Host
Head of Entrepreneurship
Franziska is responsible for managing the organization’s startup services and entrepreneurship programs.
Judges
-
Bio
Danielle DeLancey
Investor, Wilmot VenturesDanielle is an investor at Wilmot Ventures, a family investment fund supporting early-stage companies led by exceptional entrepreneurs. At Wilmot, she focuses on complex technologies that seek to solve problems in behind the times markets. Danielle earned a bachelor degree in organizational development with an emphasis in leadership effectiveness from Vanderbilt University followed by a master’s degree in policy from the Harvard Graduate School of Education.
-
Bio
Anne DeGheest
EntrepreneurAnne pioneered the HealthTech or Digital Health space as a healthcare executive, an entrepreneur, angel investor, corporate advisor and mentor capitalist. She is the founder of HealthTech Capital and MedStars. Since she founded MedStars in 1986, she has been a corporate development advisor to large healthcare companies and a mentor capitalist specializing in investing and mentoring early stage companies in healthcare.
-
Bio
Aimée Leifer
Partner, Calibrate VenturesAimée is a partner at Calibrate Ventures, where she invests in and supports companies with a focus on automation (across sectors and technologies – from HealthTech to AgTech to Manufacturing and beyond). She serves as an Independent Board Member of Broadly and an angel investor in, board member of, and advisor to various early-stage companies including health technology, job placement, wellness, real estate, and consumer packaged goods companies.
Partner
-
swissnex Demo Day Fall 2020
We’re excited to announce that for the second time this year, we’re taking our swissnex Startup Bootcamp online, making our Demo Day available for audiences worldwide.